Analysts' ratings for Vertex Pharmaceuticals VRTX over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings, showcasing the ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by Royal Bank of Canada from $408.00 to $420.00 in a research report sent to investors on Tuesday morning ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...

Vertex Pharmaceuticals saw a notable 20.53% share price increase over the last quarter, which coincided with several key developments in its Type 1 Diabetes (T1D) initiatives. The company ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ ... Learn More » First, a bit of background on Vertex's CF program since it's so central to the company's growth.

Vertex Pharmaceuticals Incorporated has a 52-week low of $377.85 and a 52-week high of $519.88. Vertex Pharmaceuticals ( NASDAQ:VRTX – Get Free Report ) last announced its quarterly earnings ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on VRTX: Disclaimer & Disclosure Report an Issue Vertex Pharmaceuticals NewsMORE Related Stocks Indices Commodities ...

Jim Lebenthal names Vertex Pharmaceuticals as his final trade. Joshua Brown says Netflix is close to its 52-week high. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley ...

Vertex Pharmaceuticals generated more than $11 ... Let's find out. First, a bit of background on Vertex's CF program since it's so central to the company's growth. The company dominates this ...